Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
IBER
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Relative Strength
IBER
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
NA
vs NA
Q3.20
N/A
NA
vs NA
Q4.20
N/A
NA
vs NA
Q1.21
N/A
NA
vs NA
Q2.21
N/A
NA
vs NA
Q3.21
N/A
NA
vs NA
Q4.21
N/A
NA
vs NA
Q1.22
+6743%
0.43
vs -0.01
Q2.22
+2850%
0.18
vs -0.01
Q3.22
+5%
0.11
vs 0.1
Sales Growth
YoY
Current
Estimates
Q2.20
NA
NA vs NA
Q3.20
NA
NA vs NA
Q4.20
NA
NA vs NA
Q1.21
NA
NA vs NA
Q2.21
NA
NA vs NA
Q3.21
NA
NA vs NA
Q4.21
NA
NA vs NA
Q1.22
NA
NA vs NA
Q2.22
NA
NA vs NA
Q3.22
NA
NA vs NA
Return on Equity
QoQ
Q2.20
NA
NA
vs NA
Q3.20
NA
NA
vs NA
Q4.20
NA
NA
vs NA
Q1.21
NA
NA
vs NA
Q2.21
0%
-0.00
vs -0.00
Q3.21
+1%
0.01
vs -0.00
Q4.21
+1%
0.01
vs 0.01
Q1.22
+6%
0.06
vs 0.01
Q2.22
+2%
0.02
vs 0.06
Q3.22
+1%
0.01
vs 0.02
Institutionnal Ownership
QoQ
Q3.20
NA
NA
vs NA
NA
Q4.20
NA
NA
vs NA
NA
Q1.21
NA
NA
vs NA
NA
Q2.21
33
33
vs NA
NA
Q3.21
39
39
vs 33
18%
Q4.21
48
48
vs 39
23%
Q1.22
49
49
vs 48
2%
Q2.22
46
46
vs 49
-6%
Q3.22
48
48
vs 46
4%
Q4.22
48
48
vs 48
NA
businesswire.com
8 hours ago
newsfilecorp.com
17 hours ago
prnewswire.com
18 hours ago
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
NYSE
-0.03Â ( -0.29%)
After-hours NaN$
0.00 (0.00%)
Relative Strenght
Volume Buzz
-47%
Earning Acce
No
Dist 52w H.
5%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How IBER compares to sector?
IBER
75x